Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
AdvanSix | ASIX | Oct 18, 2024 | 30.09 | -1.73 |
Advantage Solutions A | ADV | Oct 18, 2024 | 3.14 | -0.63 |
Advent | AVK | Oct 18, 2024 | 11.42 | +0.09 |
Advent Technologies A | ADN | Oct 18, 2024 | 1.84 | +6.98 |
Adverum Biotechnologies | ADVM | Oct 18, 2024 | 8.48 | +4.95 |
AdvisorShares Pure US Cannabis ETF | MSOS | Oct 18, 2024 | 7.17 | +0.70 |
Advisorshares Star Global Buy-Write ETF | VEGA | Oct 18, 2024 | 44.09 | +0.22 |
AECOM | ACM | Oct 18, 2024 | 107.89 | +0.32 |
Aegon N.V ADR | AEG | Oct 18, 2024 | 6.43 | +1.10 |
Aehr Test Systems | AEHR | Oct 18, 2024 | 15.68 | +6.02 |
Aemetis | AMTX | Oct 18, 2024 | 3.00 | 0.00 |
Aeon Biopharma | AEON | Oct 18, 2024 | 1.06 | -1.85 |
AerCap Holdings | AER | Oct 18, 2024 | 97.49 | -0.49 |
Aeries Technology | AERT | Oct 18, 2024 | 1.79 | -6.77 |
Aerospace & Defense Powershares | PPA | Oct 18, 2024 | 119.29 | +0.10 |
Aerovate Therapeutics | AVTE | Oct 18, 2024 | 2.37 | +2.16 |
AeroVironment | AVAV | Oct 18, 2024 | 216.97 | +0.62 |
AerSale | ASLE | Oct 18, 2024 | 5.33 | +0.38 |
AES | AES | Oct 18, 2024 | 17.47 | +1.28 |
Aetherium Acquisition A | GMFI | Oct 18, 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | Oct 18, 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | Oct 18, 2024 | 0.38 | +0.64 |
Aeva Technologies | AEVA | Oct 18, 2024 | 4.16 | +14.60 |
AEye A | LIDR | Oct 18, 2024 | 1.20 | +3.45 |
AFC Gamma | AFCG | Oct 18, 2024 | 10.38 | -0.76 |
Affiliated Managers Group | AMG | Oct 18, 2024 | 194.62 | -0.81 |
Affimed N.V. | AFMD | Oct 18, 2024 | 3.55 | +7.25 |
Affinity Bancshares | AFBI | Oct 18, 2024 | 21.21 | -0.33 |
Affirm A | AFRM | Oct 18, 2024 | 44.54 | +1.39 |
Aflac | AFL | Oct 18, 2024 | 114.50 | -0.43 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.